Optimizing antibody production for toxicology involves several strategies, including choosing the appropriate animal model, optimizing the immunization protocol, and selecting the right adjuvants. Recombinant DNA technology and phage display are also used to produce antibodies with improved specificity and affinity. High-throughput screening methods are employed to identify the best antibodies for a given toxin, ensuring both efficacy and reliability in their application.
